Amir Goudarzi, PhD

Head, Process Engineering, BCMS at UCB

Amir Goudarzi has more than 15 years of experience in bioprocess industry. In his latest role at UCB Pharma in Belgium, Amir lead global tech transfer of (early to late stage) biologics from development labs to pilot to full commercial scale. Amir & his team look after addressing industrialization of these processes by tackling manufacturing challenges, scale up/scale down rationals, automation integrations and plant engineering aspects at UCB’s internal & external BioDS manufacturing sites. With broader UCB development teams, Amir devised the long range development & investment plans for UCB to enable implementation of state of the art bioprocesses in state of the art facilities at UCB. As of May-2022, as Sr Director BioProcess Technologies, Amir will join Bayer’s global advanced manufacturing teams with focus on CGT/mAbs DS & DP processes.